🇺🇸 FDA
Patent

US 8710081

5-lipoxygenase-activating protein (FLAP) inhibitors

granted A61PA61P1/00A61P1/04

Quick answer

US patent 8710081 (5-lipoxygenase-activating protein (FLAP) inhibitors) held by Panmira Pharmaceuticals, LLC expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Panmira Pharmaceuticals, LLC
Grant date
Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P1/00, A61P1/04, A61P11/00, A61P11/02